Evotec SE EVO
NASDAQ EVO
$1.42 +0.08 (+5.95%)
At close: Oct 14, 2026 · 4:00 PM EDT

Evotec SE (EVO) Liabilities from Discontinued Operations (2024 - 2025)

Updated

Evotec SE's Liabilities from Discontinued Operations came in at $46.86 million for the quarter ended Sep 30, 2025, up 474.9% from $8.15 million a year earlier.

Analysis

Evotec SE (EVO) Liabilities from Discontinued Operations (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.58 Bn 35.28 Bn 1.44 Bn
2 Medpace Holdings 17.39 Bn 15.45 Bn 201.64 Mn
3 Charles River Laboratories International 14.59 Bn 13.78 Bn 363.37 Mn
4 Icon 13.27 Bn 10.38 Bn 479.29 Mn
5 Fortrea Holdings 2.03 Bn 1.41 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 716.57 Mn -45.52 Mn 18.44 Mn
7 Evotec SE 506.10 Mn -1.10 Bn -
8 Champions Oncology 66.85 Mn 41.93 Mn 7.70 Mn
9 MindWalk Holdings 63.92 Mn 27.58 Mn 1.61 Mn
10 Natural Alternatives International 6.75 Mn -21.33 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 47.03 Mn
Sep 30, 2024 8.29 Mn
API Access

Evotec SE Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=EVO&period=max&api_key=YOUR_API_KEY